Givaudan stock trades steadily as fragrance leader reports higher sales and margins

Givaudan stock reflects the Swiss groups profile as a global fragrance and flavors leader, with recent results showing higher sales, improved EBITDA margin and a solid dividend while investors watch volumes and pricing.

Givaudan stock represents one of the key names in the global fragrance and flavors industry, with the Swiss group Givaudan SA (ISIN CH0010645932) seen as a benchmark for consumer and fragrance ingredients. In its full year 2023 reporting, according to information published by Givaudan on its investor portal, the company delivered sales of CHF 6.9 billion, which marked an increase of around 4.8% compared with the CHF 6.6 billion recorded in 2022, underlining its ability to grow through a challenging consumer environment. The same set of results showed an EBITDA of CHF 1.5 billion for 2023 versus about CHF 1.4 billion in 2022, indicating that the group slightly expanded operating profitability despite input cost pressures. For investors, this combination of mid single digit sales growth and EBITDA expansion underpins the long term premium profile that many associate with Givaudan stock.

Revenue growth is one of the central metrics for Givaudan SA, and recent reporting underlines the importance of volumes and pricing. According to the companys 2023 figures on its investor relations page, the Fragrance & Beauty division generated sales of around CHF 3.2 billion in 2023 compared with roughly CHF 3.1 billion a year earlier, a year on year increase of about 3.2%. In parallel, the Taste & Wellbeing division reported sales of approximately CHF 3.7 billion in 2023 versus about CHF 3.5 billion in 2022, a growth rate of close to 5.7% year on year helped by contributions from beverage, savory and plant based solutions. Investors looking at Givaudan stock often focus on this balance between the two divisions, with Taste & Wellbeing providing more exposure to food and beverage consumption trends and Fragrance & Beauty linked to personal care and fine fragrance cycles.

Profitability metrics also play a crucial role for Givaudan stock. In the full year 2023 communication, the company highlighted an EBITDA margin around 21.7%, which was modestly higher than the approximately 21.3% reported for 2022, suggesting that cost efficiency measures and selective pricing helped offset inflation in raw materials and logistics. Net income attributable to shareholders for 2023 stood close to CHF 788 million compared with roughly CHF 750 million in 2022, implying a growth of around 5% and supporting the ability to sustain dividend payments. Earnings per share, calculated on a weighted average basis, reached approximately CHF 86 in 2023 against about CHF 82 in 2022, a year on year EPS increase of nearly 4.9%. For holders of Givaudan stock, such incremental EPS progress is a key determinant of valuation, particularly given the companys long history on the SIX Swiss Exchange.

The balance sheet and cash generation underpin the resilience of Givaudan SA. Based on the 2023 results data presented in the companys investor materials, operating cash flow reached around CHF 1.1 billion, which was higher than the approximate CHF 1.0 billion reported in 2022, indicating improved cash conversion from earnings. Capital expenditure for 2023 was near CHF 300 million, broadly in line with the prior year, and focused on capacity, automation and digital platforms supporting both Fragrance & Beauty and Taste & Wellbeing. Net debt stood around CHF 4.0 billion at the end of 2023 compared with roughly CHF 3.9 billion a year earlier, keeping leverage at a level that the company describes as consistent with its investment grade ambitions and allowing room for selective acquisitions. For investors following Givaudan stock, the interplay between net debt, EBITDA and cash flow is central to assessing room for further portfolio expansion.

Dividend policy provides another lens for Givaudan stock. In the context of its 2023 results, Givaudan SA proposed a cash dividend of CHF 68 per share, up from CHF 66 per share related to the 2022 financial year, representing an increase of about 3% and signaling confidence in long term cash generation. This level implies a payout ratio that remains robust but manageable when set against the roughly CHF 86 earnings per share for 2023, leaving capital available for reinvestment and potential buybacks. Historically, the company has emphasized gradually rising dividends as part of its shareholder return framework, which appeals to investors seeking stable income from a large cap ingredient supplier. The modestly higher dividend per share, aligned with EPS growth and strong cash flow, is one of the fundamental features that help Givaudan stock stand out in the Swiss equity universe.

Revenue up 4.8 percent in 2023

Revenue trends are a focal point for Givaudan stock because they reveal how the business navigates changing consumer demand and input costs. As outlined in the 2023 full year figures, overall sales of CHF 6.9 billion were about CHF 0.3 billion higher than the CHF 6.6 billion achieved in 2022, a year on year increase of 4.8% that came despite volatility in some end markets. Within this growth profile, the company noted that price increases contributed meaningfully, as it sought to pass through higher raw material and energy costs, while volumes in certain categories remained under pressure. Taste & Wellbeing showed comparatively stronger momentum, with high single digit growth in emerging markets and solid performance in plant based products, while developed market growth was more modest. In Fragrance & Beauty, fine fragrance benefited from demand for prestige brands, whereas some consumer fragrance categories faced normalization after earlier strength.

The geographic mix adds another layer to interpretation of Givaudan stock metrics. Givaudan SA reported that in 2023, sales in Europe, Africa and the Middle East accounted for roughly 34% of total revenue, the Americas contributed around 31%, and Asia Pacific represented about 35%, reflecting a diversified footprint across mature and emerging markets. Growth in Asia Pacific was slightly above the group average thanks to expansion in China and other key markets, while the Americas saw more moderate growth given mixed dynamics in North America and Latin America. Such diversification helps mitigate regional shocks, but it also means that currency movements, including the Swiss franc against the euro and US dollar, can materially influence reported figures. For investors viewing Givaudan stock as a long term holding, the exposure to emerging market consumer growth and prestige fragrance demand is often part of the investment case.

Margin development further affects perceptions of Givaudan stock. The EBITDA margin improvement from roughly 21.3% in 2022 to around 21.7% in 2023 suggests that the company was able to navigate cost inflation through pricing and productivity measures. Initiatives such as process automation, portfolio optimization and procurement efficiencies contributed to stabilizing margins even as certain input costs remained elevated compared with pre pandemic levels. The company also highlighted ongoing programs to streamline its manufacturing footprint and reduce energy usage, which could support margins over time. For investors, a stable or slightly rising margin profile in a period of cost volatility reinforces the view that Givaudan SA can maintain a premium positioning relative to many peers in the ingredients and specialty chemicals space.

EBITDA reaches CHF 1.5 billion

The EBITDA figure of around CHF 1.5 billion for 2023 compared with CHF 1.4 billion in 2022 is a practical indicator for Givaudan stock analysts assessing operating performance. This increase of about CHF 0.1 billion reflects both the sales expansion and the margin improvement described in company materials. EBITDA in the Taste & Wellbeing division benefited from product mix and pricing, while Fragrance & Beauty EBITDA was supported by fine fragrance and fashion driven launches. The group continues to invest in innovation centers and sensory platforms to support new products, which is visible in research and development expenses that remained a steady share of sales. For valuation work on Givaudan stock, EBITDA and its trajectory are often used in enterprise value multiples, particularly given the relatively high proportion of intangible assets and acquired businesses on the balance sheet.

Net income development is also relevant to Givaudan stock holders. The approximate CHF 788 million net income attributable to shareholders in 2023, up from around CHF 750 million in 2022, reflects a combination of higher operating profit and relatively stable finance costs. The companys interest expenses remained manageable, supported by a mix of fixed and floating rate debt, and tax expenses tracked profit growth without major one off items. This resulted in earnings per share close to CHF 86, a figure that, when compared to the CHF 82 per share of the prior year, provided around 4.9% EPS growth. Such EPS progress often matters for long term holders who value the companys consistent ability to grow earnings in low double digits over multi year periods, even if shorter term fluctuations occur.

Cash flow dynamics are another cornerstone of analysis for Givaudan stock. Operating cash flow of roughly CHF 1.1 billion in 2023 compared with the CHF 1.0 billion in 2022 indicates that the company converted a solid portion of its EBITDA into cash, allowing for capital expenditure, dividends and selective acquisitions. Working capital management, including inventory and receivables, remained a focus as the company balanced supply chain resilience with efficiency. While net debt edged higher to about CHF 4.0 billion from CHF 3.9 billion, leverage ratios remained within the range that management considers compatible with its objectives. For debt investors and equity holders alike, the combination of strong cash flow and disciplined leverage supports the overall investment case for Givaudan stock as a relatively defensive, cash generative name in the consumer ingredients sector.

Fragrance & Beauty portfolio

Beyond the headline figures, a brief look at the product portfolio helps explain why Givaudan stock is often linked with long term growth themes. The Fragrance & Beauty division develops and produces a wide range of fragrance compounds used in fine perfumes, personal care, household products and fabric care, as well as beauty actives aimed at skin care, hair care and cosmetics. According to recent company presentations, this division contributed around CHF 3.2 billion to group sales in 2023, with fine fragrance and consumer products being the largest sub segments. Innovation plays a prominent role, with new molecules, naturals and biotechnology based ingredients supporting evolving consumer preferences for sustainability and wellness. For investors, the Fragrance & Beauty portfolio offers exposure to branded consumer goods growth through ingredients rather than direct consumer marketing.

Givaudan stock on SIX Swiss Exchange

Givaudan stock is listed on the SIX Swiss Exchange, providing a liquid market for institutional and retail investors. The company is part of the Swiss large cap universe and considered a key component of indices covering the Swiss market and European chemicals and ingredients. Market data pages from Swiss exchange related portals indicate that Givaudan SA shares trade under the ticker SIX: GIVN, with pricing in Swiss francs. The stock tends to display characteristics associated with defensive consumer exposure, including sensitivity to long term consumption trends and less exposure to cyclical industrial capital spending than many diversified chemicals peers. Valuation metrics such as the price to earnings ratio and enterprise value to EBITDA multiple are often above the average for broader European indices, reflecting the companys perceived quality and market position.

For investors looking at the latest trading context of Givaudan stock, price levels on the SIX Swiss Exchange are a key reference point. Recent market data show the shares trading at a price in the low to mid CHF 3,000 range, with a market capitalization around CHF 30 billion, placing the company among the larger constituents of the Swiss equity market. Over the previous twelve months, the stock has typically fluctuated within a band spanning roughly CHF 2,600 at the lower end to around CHF 3,400 at the upper end, a range that reflects changes in investor sentiment regarding consumer demand, input costs and broader interest rate dynamics. Such movements underline how even relatively defensive names like Givaudan SA can experience valuation shifts as macro assumptions evolve, though the underlying business often remains more stable than the share price might suggest.

Givaudan key data

• Company: Givaudan SA
• ISIN: CH0010645932
• Ticker: SIX: GIVN
• Trading venue: SIX Swiss Exchange
• Price (as of 25 July 2026, 16:30 CET): 3,150 CHF
• Market capitalization: 29,800,000,000 CHF (as of 25 July 2026)
• Sector / Industry: Consumer Staples / Flavors and Fragrances
• Index membership: SMI
• Next earnings date: 30 July 2026